DiaGen AI / Investors
Two validated AI platforms, active partner deployments, and a capital-light structure built to scale. Download the deck for the full investment case.
Investor materials
DiaGen AI · Investor deck
Company overview, platform validation, active partnerships, pipeline progress and the capital structure — in one deck.
Why DiaGen
DiaGen keeps the models proprietary while pushing synthesis cost onto institutional partners and compute cost onto an incentivized network — shifting spend from fixed infrastructure to variable and performance-based.
Results come back from partner labs with no stake in the model performing well — not from benchmarks DiaGen wrote itself.
Both platforms are in active partner deployment today, with revenue-share and co-development agreements already signed.
DiaGen retains or co-owns the high-value intellectual property generated across its partner network.
For platform access, catalog partnering or co-development enquiries.
IR@diagen.ai